Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease

Table 1 Categories of SARS-2 positive samples used in this study

	All samples	Deceased	Severe	Ambulatory
Total	120^a	58	26	36
No comorbidities	70	19	16	35
Comorbidities^b	50 (41.7%)	39 (67.2%)	10 (38.5%)	1 (2.8%)
1 comorbidity	24 (20%)	16 (27.6%)	7 (27%)	1 (2.8%)
≥ 2 comorbidities	26 (21.7%)	23 (40.4%)	3 (11.5%)	0

^aNumber of samples in each category
^bsamples from patients with comorbidities were divided into two groups; with 1 comorbidity, and with 2 or more comorbidities
Conditions considered comorbidity: Obesity BMI index > 30, smoker, high blood pressure, diabetes, immunosuppression, HIV, COPD, kidney insufficiency, asthma, chronic disease

ISSN: 1471-2334